Patients experiencing constipationa side effect reported in clinical trials of GLP-1 agonists (though rates vary by product and dose)may benefit from gradually working towards the recommended 30 grams daily, ensuring adequate fluid intake alongside
Once thawed, inspect the solution carefully
This longer half-life means semaglutide maintains more consistent blood levels throughout the weekly dosing interval, and the wearing-off effect tends to be less pronounced
however, individuals already taking glucose-lowering medicines (including insulin) may be at increased risk of hypoglycaemia if GH-mediated effects alter their insulin sensitivity Injection site reactions, including pain, redness, and infection risk For retatrutide , the side effect profile observed in clinical trials is consistent with that of other GLP-1 receptor agonists and includes nausea, vomiting, diarrhoea, and constipation
When a drug is listed on the FDAs Drug Shortage List, Section 503A and 503B compounding pharmacies gain legal authorization to compound copies of that drug, even though the brand-name version is commercially available (just not in sufficient supply)
While there are no major known drug-to-drug contraindications, some antidepressants may influence the rate of weight loss or overlap with certain gastrointestinal side effects